127 related articles for article (PubMed ID: 9191963)
1. Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives.
Kaneko M; Saito Y; Saito H; Matsumoto T; Matsuda Y; Vaught JL; Dionne CA; Angeles TS; Glicksman MA; Neff NT; Rotella DP; Kauer JC; Mallamo JP; Hudkins RL; Murakata C
J Med Chem; 1997 Jun; 40(12):1863-9. PubMed ID: 9191963
[TBL] [Abstract][Full Text] [Related]
2. K-252a promotes survival and choline acetyltransferase activity in striatal and basal forebrain neuronal cultures.
Glicksman MA; Forbes ME; Prantner JE; Neff NT
J Neurochem; 1995 Apr; 64(4):1502-12. PubMed ID: 7891076
[TBL] [Abstract][Full Text] [Related]
3. K-252a and staurosporine promote choline acetyltransferase activity in rat spinal cord cultures.
Glicksman MA; Prantner JE; Meyer SL; Forbes ME; Dasgupta M; Lewis ME; Neff N
J Neurochem; 1993 Jul; 61(1):210-21. PubMed ID: 8515268
[TBL] [Abstract][Full Text] [Related]
4. CEP-1347/KT7515 prevents motor neuronal programmed cell death and injury-induced dedifferentiation in vivo.
Glicksman MA; Chiu AY; Dionne CA; Harty M; Kaneko M; Murakata C; Oppenheim RW; Prevette D; Sengelaub DR; Vaught JL; Neff NT
J Neurobiol; 1998 Jun; 35(4):361-70. PubMed ID: 9624618
[TBL] [Abstract][Full Text] [Related]
5. Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival.
Wang LH; Paden AJ; Johnson EM
J Pharmacol Exp Ther; 2005 Mar; 312(3):1007-19. PubMed ID: 15525794
[TBL] [Abstract][Full Text] [Related]
6. Preservation of cholinergic activity and prevention of neuron death by CEP-1347/KT-7515 following excitotoxic injury of the nucleus basalis magnocellularis.
Saporito MS; Brown ER; Carswell S; DiCamillo AM; Miller MS; Murakata C; Neff NT; Vaught JL; Haun FA
Neuroscience; 1998 Sep; 86(2):461-72. PubMed ID: 9881861
[TBL] [Abstract][Full Text] [Related]
7. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
8. The role of tropomyosin-related kinase receptors in neurotrophin-induced rapid eye movement sleep in the cat.
Yamuy J; Ramos O; Torterolo P; Sampogna S; Chase MH
Neuroscience; 2005; 135(2):357-69. PubMed ID: 16125858
[TBL] [Abstract][Full Text] [Related]
9. The staurosporine-like compound L-753,000 (NB-506) potentiates the neurotrophic effects of neurotrophin-3 by acting selectively at the TrkA receptor.
Pollack S; Young L; Bilsland J; Wilkie N; Ellis S; Hefti F; Broughton H; Harper S
Mol Pharmacol; 1999 Jul; 56(1):185-95. PubMed ID: 10385700
[TBL] [Abstract][Full Text] [Related]
10. K-252b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by neurotrophin-3.
Knüsel B; Kaplan DR; Winslow JW; Rosenthal A; Burton LE; Beck KD; Rabin S; Nikolics K; Hefti F
J Neurochem; 1992 Aug; 59(2):715-22. PubMed ID: 1629741
[TBL] [Abstract][Full Text] [Related]
11. K-252a inhibits the increase in c-fos transcription and the increase in intracellular calcium produced by nerve growth factor in PC12 cells.
Lazarovici P; Levi BZ; Lelkes PI; Koizumi S; Fujita K; Matsuda Y; Ozato K; Guroff G
J Neurosci Res; 1989 May; 23(1):1-8. PubMed ID: 2501508
[TBL] [Abstract][Full Text] [Related]
12. K-252b is a selective and nontoxic inhibitor of nerve growth factor action on cultured brain neurons.
Knüsel B; Hefti F
J Neurochem; 1991 Sep; 57(3):955-62. PubMed ID: 1861160
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the K-252a-induced increase in calcium uptake in PC12 cells.
Nikodijevic B; Aschkenasy M; Dickens G; Lachance C; Guroff G
J Neurosci Res; 1995 Mar; 40(4):494-8. PubMed ID: 7616609
[TBL] [Abstract][Full Text] [Related]
14. Effect of exogenous neurotrophins on Trk receptor phosphorylation, cell proliferation, and neurotrophin secretion by cells isolated from the human lamina cribrosa.
Lambert WS; Clark AF; Wordinger RJ
Mol Vis; 2004 Apr; 10():289-96. PubMed ID: 15105791
[TBL] [Abstract][Full Text] [Related]
15. A radioactive binding assay for inhibitors of trkA kinase.
Knight E; Connors TJ; Maroney AC; Angeles TS; Hudkins RL; Dionne CA
Anal Biochem; 1997 May; 247(2):376-81. PubMed ID: 9177701
[TBL] [Abstract][Full Text] [Related]
16. Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Murray SS; Piccenna LG; Lopes EC; Kilpatrick TJ; Cheema SS
J Neurosci Res; 2004 Oct; 78(2):193-9. PubMed ID: 15378612
[TBL] [Abstract][Full Text] [Related]
17. A nerve growth factor-induced retrograde survival signal mediated by mechanisms downstream of TrkA.
Mok SA; Campenot RB
Neuropharmacology; 2007 Feb; 52(2):270-8. PubMed ID: 16949623
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, modeling, and in vitro activity of (3'S)-epi-K-252a analogues. Elucidating the stereochemical requirements of the 3'-sugar alcohol on trkA tyrosine kinase activity.
Gingrich DE; Yang SX; Gessner GW; Angeles TS; Hudkins RL
J Med Chem; 2005 Jun; 48(11):3776-83. PubMed ID: 15916429
[TBL] [Abstract][Full Text] [Related]
19. Interactions between beta-neuregulin and neurotrophins in motor neuron apoptosis.
Ricart K; J Pearson R; Viera L; Cassina P; Kamaid A; Carroll SL; Estévez AG
J Neurochem; 2006 Apr; 97(1):222-33. PubMed ID: 16524373
[TBL] [Abstract][Full Text] [Related]
20. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
